Global support for a quality solution

We lead innovation in peptide API’s to the benefit of millions of patients

Contact us

Market leader in peptide API manufacturing and services

PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API). 

Ad hoc announcements pursuant to Art. 53 LR

PolyPeptide with encouraging progress within custom projects pipeline – however with lower profitability in the first half of 2022

19 Aug 2022 - Baar, 19 August 2022 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligo-nucleotide-based active pharmaceutical ingredients, today announced its detailed results […]

Read more
Ad hoc announcements pursuant to Art. 53 LR

PolyPeptide provides market update

12 Jul 2022 - Media Release – ad hoc announcement pursuant to Art. 53 LR Baar, 12 July 2022 – PolyPeptide Group AG (PolyPeptide), a global leader in peptide and […]

Read more

PolyPeptide video

PolyPeptide Group - Ahead on green peptide chemistry